Suchergebnisse - "Brunetti, Oronzo"

PubPharm (12)

1

Clinical insights and prognostic factors from an advanced biliary tract cancer case series : a real-world analysis

enthalten in: Journal of chemotherapy (Florence, Italy) | 2022

von Filippi, R. | Leone, F. | Fornaro, L. | +18

2

Cytotoxic T-Lymphocyte Antigen-4 in Colorectal Cancer : Another Therapeutic Side of Capecitabine

enthalten in: Cancers | 2021

von Derakhshani, A. | Hashemzadeh, S. | Asadzadeh, Z. | +12

3

COVID Vaccination in Cancer Patients : What Vaccination Priority Strategies Should There Be?

enthalten in: Frontiers in oncology | 2021

von Silvestris, N. | Brunetti, O. | Bernardini, R. | +1

4

Moving the Target on the Optimal Adjuvant Strategy for Resected Pancreatic Cancers : A Systematic Review with Meta-Analysis

enthalten in: Cancers | 2020

von Galvano, A. | Castiglia, M. | Rizzo, S. | +12

5

Pancreatic Enzyme Replacement Therapy in Pancreatic Cancer

enthalten in: Cancers | 2020

von Pezzilli, R. | Caccialanza, R. | Capurso, G. | +3

6

The Italian Rare Pancreatic Exocrine Cancer Initiative

enthalten in: Tumori | 2019

von Brunetti, O. | Luchini, C. | Argentiero, A. | +26

ErratumIn: Tumori. 2020 Dec;106(6):526. - PMID 32172676

7

Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First and Second Line Therapy

enthalten in: Cancers | 2019

von Brunetti, O. | Badalamenti, G. | De Summa, S. | +12

8

Strategies to Improve Cancer Immune Checkpoint Inhibitors Efficacy, Other Than Abscopal Effect : A Systematic Review

enthalten in: Cancers | 2019

von Longo, V. | Brunetti, O. | Azzariti, A. | +4

9

Selecting patients for gastrectomy in metastatic esophago-gastric cancer : clinics and pathology are not enough

enthalten in: Future oncology (London, England) | 2017

von Fornaro, L. | Fanotto, V. | Musettini, G. | +24

ErratumIn: Future Oncol. 2018 Mar;14 (6):577. - PMID 29441800

10

Management of patients with end-stage renal disease undergoing chemotherapy : recommendations of the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Nefrologia (SIN)

enthalten in: ESMO open | 2017

von Pedrazzoli, P. | Silvestris, N. | Santoro, A. | +9